23 Recruiting Bladder Cancer Phase 2 Clinical Trials
Active phase 2 studies for bladder cancer enrolling across the USA. Verify eligibility and contact site coordinators.
All Bladder Cancer studiesPhase 2 Studies for Bladder Cancer
Study of CAbozantinib in Combination with AtezolizumaB for Muscle-Invasive BladdEr Cancer
📍 Washington University School of Medicine — St Louis, Missouri
View Study & Checklist ➔Trimodality Therapy With/Out Durvalumab to Treat Patients With Muscle-Invasive Bladder Cancer
📍 Tom Baker Cancer Centre — Calgary, Alberta
View Study & Checklist ➔A Phase II Study of Atezolizumab in Combination With Cisplatin + Gemcitabine Before Surgery to Remove the Bladder Cancer
📍 Hartford Healthcare Cancer Institute @ Hartford Hospital — Hartford, Connecticut
View Study & Checklist ➔Prophylactic Cranial Irradiation (PCI) for Small Cell Carcinoma of the Urothelium
📍 University of Texas MD Anderson Cancer Center — Houston, Texas
View Study & Checklist ➔Adjuvant Nivolumab Following Chemo-Radiation in Localized Muscle-Invasive Bladder Cancer
📍 Moffitt Cancer Center — Tampa, Florida
View Study & Checklist ➔QUILT-3.032: A Multicenter Clinical Trial of Intravesical Bacillus Calmette-Guerin (BCG) in Combination With ALT-803 (N-803) in Patients With BCG Unresponsive High Grade Non-Muscle Invasive Bladder Cancer
📍 Alaska Clinical Research Center — Anchorage, Alaska
View Study & Checklist ➔Window of Opportunity Study of Pembrolizumab Alone and in Combinations in Bladder Cancer
📍 Lineberger Comprehensive Cancer Center — Chapel Hill, North Carolina
View Study & Checklist ➔A Clinical Study of Intismeran Autogene (V940) Treatment and Pembrolizumab in People With Bladder Cancer (V940-005/INTerpath-005)
📍 UCLA Hematology/Oncology - Westwood (Building 200 Suite 140)-Department of Urology/Institute of Uro ( Site 0104) — Los Angeles, California
View Study & Checklist ➔Intravenous (IV) Vitamin C With Chemotherapy for Cisplatin Ineligible Bladder Cancer Patients
📍 The University of Kansas Cancer Center (KUCC) — Fairway, Kansas
View Study & Checklist ➔A Study of Oral Erdafitinib in People With Recurrent Non-Invasive Bladder Cancer
📍 Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities) — Basking Ridge, New Jersey
View Study & Checklist ➔Pembrolizumab (MK-3475) and Bacillus Calmette-Guérin (BCG) as First-Line Treatment for High-Risk T1 Non-Muscle-Invasive Bladder Cancer (NMIBC) and High-Grade Non-Muscle-Invasive Upper Tract Urothelial Carcinoma (NMI-UTUC)]
📍 Memorial Sloan Kettering Basking Ridge (All Protocol Activities) — Basking Ridge, New Jersey
View Study & Checklist ➔A Study to Test the Safety of Immunotherapy With Nivolumab Alone or With Ipilimumab Before Surgery for Bladder Cancer Patients Who Are Not Suitable for Chemotherapy
📍 Memorial Sloan Kettering Basking Ridge (All Protocol Activities) — Basking Ridge, New Jersey
View Study & Checklist ➔Fluorouracil, Leucovorin, Gemcitabine, and Cisplatin in Treating Patients With Metastatic or Unresectable Adenocarcinoma of the Urothelium or Urachal Remnant
📍 University of Texas MD Anderson Cancer Center — Houston, Texas
View Study & Checklist ➔Intravesical GEM/DOCE for HR BCG-Unresponsive NMIBC
📍 University of Iowa — Iowa City, Iowa
View Study & Checklist ➔Enfortumab Vedotin and Stereotactic Radiation for Localized, Cisplatin Ineligible Muscle Invasive Bladder Cancer
📍 UT Southwestern Medical Center — Dallas, Texas
View Study & Checklist ➔Enfortumab Vedotin and Pembrolizumab Combined With Radiotherapy in Muscle Invasive Bladder Cancer
📍 University of California, San Francisco — San Francisco, California
View Study & Checklist ➔A Clinical Study of MK-3120 in People With Bladder Cancer (MK-3120-003)
📍 Michael G Oefelein Clinical Trials ( Site 0005) — Bakersfield, California
View Study & Checklist ➔Gemcitabine/Cisplatin Plus Cemiplimab With or Without Fianlimab in Localized Muscle-invasive Bladder Cancer (NeoSTOP-IT)
📍 Columbia University Irving Medical Center/ New York Presbyterian Hospital — New York, New York
View Study & Checklist ➔Intravenous Ascorbate Plus Gemcitabine/Carboplatin: A Novel and Cost-Effective Alternative With Evident Efficacy in Patients With Muscle Invasive Bladder Cancer
📍 Holden Comprehensive Cancer Center - The University of Iowa — Iowa City, Iowa
View Study & Checklist ➔Intravesical Gemcitabine and Docetaxel for Low Grade Intermediate Risk Bladder Cancer
📍 University of Florida — Gainesville, Florida
View Study & Checklist ➔Dutasteride in Patients With Low Grade Non-muscle Invasive Bladder Cancer
📍 CHU de Québec - Université Laval — Québec, Quebec
View Study & Checklist ➔KEYMAKER-U04 Substudy 04D: A Clinical Study of New Treatments Given With Enfortumab Vedotin and Pembrolizumab in People With Urothelial Cancer (MK-3475-04D/KEYMAKER-U04)
📍 UCSF Medical Center at Mission Bay ( Site 5044) — San Francisco, California
View Study & Checklist ➔Luminal Bladder Cancer Effective Response to Neoadjuvant Chemotherapy (LUMBER-NAC)
📍 Rutgers Cancer Institute — New Brunswick, New Jersey
View Study & Checklist ➔